Caroline Rousseau

10PUBLICATIONS
28CO-AUTHORS
Predictive and prognostic markersCancer diagnosisMolecular targetsNatural language processingRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Dec 03, 2025
18F-Fluorodeoxyglucose PET-CT evaluation after one course of neoadjuvant therapy fails to predict pCR in HER2 + BC patients: a prospective and multicentric French study.

M Chanchou, M A Mouret-Reynier, I Molnar

|Nov 01, 2025
Prospective pilot study with [89Zr]Zr-girentuximab PET/CT: CA-IX imaging in metastatic triple negative breast cancer (OPALESCENCE).

Caroline Rousseau, M F Heyman, L Ferrer

|Apr 14, 2025
Preclinical and Clinical Feasibility Studies as the First Step Before Forthcoming Intravesical Instillation of [211At]At-anti-CA-IX Antibody (ATO-101™) Study in Patients with Non-Muscle-Invasive Bladder Cancer Unresponsive to Standard of Care.

Caroline Rousseau, Pierre Baumgartner, Marie-Françoise Heymann

|Mar 20, 2025
Large Language Models as Decision-Making Tools in Oncology: Comparing Artificial Intelligence Suggestions and Expert Recommendations.

Loic Ah-Thiane, Pierre-Etienne Heudel, Mario Campone

|Sep 28, 2024
Are Dual-Phase 18F-Fluorodeoxyglucose PET-mpMRI Diagnostic Performances to Distinguish Brain Tumour Radionecrosis/Recurrence after Cranial Radiotherapy Usable in Routine?

Axel Cailleteau, Ludovic Ferrer, Delphine Geffroy

|Jun 22, 2023
The Sentinel Lymph Node in Treatment Planning: A Narrative Review of Lymph-Flow-Guided Radiotherapy.

Loic Ah-Thiane, Caroline Rousseau, Maud Aumont

Pageof 2

Frequent Collaborators

4 joint publications

Stéphane Supiot

2 joint publications

Axel Cailleteau

2 joint publications

Loic Ah-Thiane

2 joint publications

Loïg Vaugier